For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251203:nRSC9617Ja&default-theme=true
RNS Number : 9617J CVS Group plc 03 December 2025
03 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 02 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 02/12/2025
Aggregate number of Ordinary Shares purchased: 17,657
Lowest price paid per share (GBp): 1,216.00
Highest price paid per share (GBp): 1,232.00
Volume weighted average price paid per share (GBp): 1,228.10
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 71,020,474 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 71,020,474 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 720,309 Ordinary Shares in aggregate at a weighted average price
of 1,216.00 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
450 1226 02/12/2025 08:04:27 1344041912372267 XLON
207 1226 02/12/2025 08:04:27 1344041912372268 XLON
72 1222 02/12/2025 08:08:08 1344041912372836 XLON
466 1218 02/12/2025 08:10:01 1344041912373242 XLON
74 1216 02/12/2025 08:12:06 1344041912373679 XLON
204 1220 02/12/2025 08:35:21 1344041912376420 XLON
109 1220 02/12/2025 08:35:21 1344041912376421 XLON
212 1222 02/12/2025 08:54:13 1344041912378445 XLON
112 1224 02/12/2025 09:00:00 1344041912379093 XLON
71 1222 02/12/2025 09:20:04 1344041912380786 XLON
1 1226 02/12/2025 10:55:15 1344041912387065 XLON
89 1226 02/12/2025 10:55:15 1344041912387066 XLON
29 1226 02/12/2025 10:55:32 1344041912387089 XLON
53 1226 02/12/2025 10:55:32 1344041912387090 XLON
25 1228 02/12/2025 11:16:50 1344041912388692 XLON
199 1228 02/12/2025 11:16:50 1344041912388693 XLON
199 1228 02/12/2025 11:16:50 1344041912388694 XLON
6 1228 02/12/2025 11:16:50 1344041912388695 XLON
120 1228 02/12/2025 11:16:50 1344041912388697 XLON
193 1228 02/12/2025 11:16:50 1344041912388696 XLON
199 1228 02/12/2025 11:16:50 1344041912388698 XLON
27 1228 02/12/2025 11:16:50 1344041912388699 XLON
615 1228 02/12/2025 11:21:35 1344041912389182 XLON
172 1228 02/12/2025 11:21:35 1344041912389181 XLON
199 1228 02/12/2025 11:21:35 1344041912389183 XLON
100 1228 02/12/2025 11:21:41 1344041912389204 XLON
58 1230 02/12/2025 11:52:17 1344041912391494 XLON
734 1230 02/12/2025 11:52:17 1344041912391495 XLON
68 1228 02/12/2025 11:53:19 1344041912391596 XLON
31 1228 02/12/2025 11:53:39 1344041912391654 XLON
199 1228 02/12/2025 12:13:00 1344041912393412 XLON
194 1228 02/12/2025 12:13:00 1344041912393413 XLON
199 1228 02/12/2025 12:13:00 1344041912393415 XLON
174 1228 02/12/2025 12:13:00 1344041912393416 XLON
25 1228 02/12/2025 12:13:00 1344041912393417 XLON
199 1228 02/12/2025 12:18:01 1344041912393962 XLON
91 1228 02/12/2025 12:18:01 1344041912393965 XLON
6 1228 02/12/2025 12:18:01 1344041912393966 XLON
102 1228 02/12/2025 12:18:01 1344041912393967 XLON
6 1228 02/12/2025 12:18:01 1344041912393968 XLON
108 1228 02/12/2025 12:18:01 1344041912393969 XLON
91 1228 02/12/2025 12:18:01 1344041912393970 XLON
11 1228 02/12/2025 12:18:01 1344041912393971 XLON
5 1228 02/12/2025 12:18:19 1344041912393982 XLON
52 1228 02/12/2025 12:18:40 1344041912393995 XLON
142 1228 02/12/2025 12:18:48 1344041912394001 XLON
175 1228 02/12/2025 12:18:48 1344041912394005 XLON
24 1228 02/12/2025 12:50:17 1344041912396438 XLON
90 1230 02/12/2025 13:04:00 1344041912397275 XLON
25 1230 02/12/2025 13:04:12 1344041912397293 XLON
85 1230 02/12/2025 13:04:12 1344041912397294 XLON
71 1230 02/12/2025 13:06:06 1344041912397447 XLON
199 1228 02/12/2025 13:17:00 1344041912398301 XLON
228 1228 02/12/2025 13:17:00 1344041912398304 XLON
585 1228 02/12/2025 13:17:00 1344041912398305 XLON
90 1230 02/12/2025 13:29:01 1344041912399141 XLON
110 1230 02/12/2025 13:51:45 1344041912400969 XLON
199 1228 02/12/2025 13:51:45 1344041912400970 XLON
231 1228 02/12/2025 13:54:21 1344041912401127 XLON
12 1228 02/12/2025 13:54:21 1344041912401128 XLON
199 1228 02/12/2025 13:54:21 1344041912401125 XLON
76 1228 02/12/2025 13:54:21 1344041912401129 XLON
123 1228 02/12/2025 13:54:21 1344041912401130 XLON
338 1228 02/12/2025 13:54:21 1344041912401131 XLON
122 1228 02/12/2025 13:54:21 1344041912401132 XLON
15 1226 02/12/2025 13:54:21 1344041912401134 XLON
131 1226 02/12/2025 13:54:21 1344041912401133 XLON
128 1226 02/12/2025 13:59:35 1344041912401593 XLON
147 1226 02/12/2025 13:59:35 1344041912401594 XLON
113 1224 02/12/2025 14:19:39 1344041912403433 XLON
47 1224 02/12/2025 14:19:39 1344041912403434 XLON
826 1226 02/12/2025 14:36:13 1344041912408403 XLON
393 1226 02/12/2025 14:37:27 1344041912408823 XLON
238 1230 02/12/2025 14:44:19 1344041912410463 XLON
7 1230 02/12/2025 14:44:19 1344041912410462 XLON
5 1230 02/12/2025 14:44:19 1344041912410461 XLON
199 1230 02/12/2025 14:44:19 1344041912410464 XLON
199 1230 02/12/2025 14:44:19 1344041912410465 XLON
199 1230 02/12/2025 14:44:19 1344041912410466 XLON
199 1230 02/12/2025 14:44:19 1344041912410467 XLON
199 1230 02/12/2025 14:44:19 1344041912410468 XLON
165 1230 02/12/2025 14:44:19 1344041912410469 XLON
18 1230 02/12/2025 14:44:19 1344041912410471 XLON
34 1230 02/12/2025 14:44:19 1344041912410470 XLON
34 1230 02/12/2025 14:44:19 1344041912410472 XLON
199 1230 02/12/2025 15:10:29 1344041912416804 XLON
101 1230 02/12/2025 15:10:29 1344041912416805 XLON
680 1230 02/12/2025 15:10:31 1344041912416833 XLON
1 1230 02/12/2025 15:10:31 1344041912416834 XLON
199 1230 02/12/2025 15:10:31 1344041912416837 XLON
11 1230 02/12/2025 15:10:31 1344041912416838 XLON
188 1230 02/12/2025 15:10:31 1344041912416839 XLON
52 1230 02/12/2025 15:10:31 1344041912416840 XLON
10 1230 02/12/2025 15:10:31 1344041912416841 XLON
42 1230 02/12/2025 15:10:31 1344041912416842 XLON
104 1230 02/12/2025 15:10:31 1344041912416844 XLON
95 1230 02/12/2025 15:10:31 1344041912416843 XLON
52 1230 02/12/2025 15:10:31 1344041912416845 XLON
147 1230 02/12/2025 15:10:31 1344041912416846 XLON
22 1230 02/12/2025 15:10:31 1344041912416847 XLON
35 1230 02/12/2025 15:10:31 1344041912416848 XLON
57 1230 02/12/2025 15:10:31 1344041912416850 XLON
142 1230 02/12/2025 15:10:31 1344041912416849 XLON
199 1230 02/12/2025 15:10:31 1344041912416851 XLON
199 1230 02/12/2025 15:10:31 1344041912416852 XLON
199 1230 02/12/2025 15:10:31 1344041912416853 XLON
199 1230 02/12/2025 15:10:31 1344041912416854 XLON
170 1230 02/12/2025 15:10:31 1344041912416855 XLON
29 1230 02/12/2025 15:10:31 1344041912416856 XLON
141 1232 02/12/2025 15:32:57 1344041912421417 XLON
180 1232 02/12/2025 15:32:57 1344041912421418 XLON
652 1232 02/12/2025 15:42:26 1344041912423086 XLON
2 1232 02/12/2025 16:14:47 1344041912430081 XLON
199 1232 02/12/2025 16:18:44 1344041912431310 XLON
180 1232 02/12/2025 16:18:44 1344041912431311 XLON
195 1232 02/12/2025 16:22:56 1344041912432621 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPGMWPUPAGMP
Copyright 2019 Regulatory News Service, all rights reserved